Skip to main content
Clinical Trials/TCTR20161115003
TCTR20161115003
Completed
Phase 2

Multimodal retinal imaging in the fellow eyes of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration

one0 sites135 target enrollmentNovember 15, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
nilateral PCV and age&#45
Sponsor
one
Enrollment
135
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 15, 2016
End Date
August 16, 2016
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • PCV and neovascular AMD patients
  • Patient who had definite diagnosis by FFA ICG
  • Patients who had FFA\-ICG, FAF, SD\-OCT in both eyes

Exclusion Criteria

  • Significant cataract or media opacity
  • Myopic maculopathy
  • Macular hole
  • Thick subfoveal haemorrhage
  • Macular geographic atrophy
  • Previous photodynamic therapy or anti\-VEGF used
  • Patient who didn't perform SD\-OCT, FAF, ICG in both eyes at the same visit

Outcomes

Primary Outcomes

Not specified

Similar Trials